FORBES-TATE for NOVARTIS, INC.
What was lobbied
6 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues related to prescription drug pricing; Issues related to Medicare, Medicaid, Cell and Gene Therapies; Issues regarding the 340B Drug Pricing Program Issues dealing with House Oversight and Reform Drug Pricing Investigation and Hearings; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues related to the implementation of H.R.2471 - Consolidated Appropriations Act, 2022; Issues related to COVID 19 funding for BARDA; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169). S.4348. - FDASLA Act of 2022 (117th Congress), S.4535 - FDASRA Act of 2022 (117th Congress), H.R.7658 - To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the Critical Path Public-Private Partnerships, provisions regarding reauthorization of FDA User Fee Programs (117th Congress).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| KRISTINA DUNKLIN | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| JEFFREY SADOSKY | — |
| JEFFREY STRUNK | — |
| BARRETT THORNHILL | — |
| DERRICK M WHITE | — |
| MICHAEL ALEXANDER WILLIAMS | — |
Medicare/Medicaid MMM
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| KRISTINA DUNKLIN | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| JEFFREY SADOSKY | — |
| JEFFREY STRUNK | — |
| BARRETT THORNHILL | — |
| DERRICK M WHITE | — |
| MICHAEL ALEXANDER WILLIAMS | — |
Trade (domestic/foreign) TRD
Issues related to prescription drug pricing; issues related to World Trade Organization IP waiver; issues related to pharmaceutical intellectual property; issues related to international trade.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| KRISTINA DUNKLIN | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| JEFFREY SADOSKY | — |
| JEFFREY STRUNK | — |
| BARRETT THORNHILL | — |
| DERRICK M WHITE | — |
| MICHAEL ALEXANDER WILLIAMS | — |
Budget/Appropriations BUD
Issues related to prescription drug pricing; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation; Issues related to the implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| KRISTINA DUNKLIN | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| JEFFREY SADOSKY | — |
| JEFFREY STRUNK | — |
| BARRETT THORNHILL | — |
| DERRICK M WHITE | — |
| MICHAEL ALEXANDER WILLIAMS | — |
Copyright/Patent/Trademark CPT
Issues related to prescription drug pricing and Intellectual Property (IP); Issues regarding the World Trade Organization's TRIPS Waiver on COVID Vaccines; Issues related to House and Senate FY 22 Budget Resolution (S. Con Res. 14) and resulting Budget Reconciliation Instructions to Committees.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| KRISTINA DUNKLIN | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| JEFFREY SADOSKY | — |
| JEFFREY STRUNK | — |
| BARRETT THORNHILL | — |
| DERRICK M WHITE | — |
| MICHAEL ALEXANDER WILLIAMS | — |
Taxation/Internal Revenue Code TAX
Issues related to implementation of H.R. 5376 - Inflation Reduction Act of 2022 (P.L. 117-169).
| Lobbyist | Covered position, as disclosed |
|---|---|
| CYNTHIA BROWN | — |
| KRISTINA DUNKLIN | — |
| JEFFREY FORBES | — |
| ELIZABETH GREER | — |
| JEFFREY SADOSKY | — |
| JEFFREY STRUNK | — |
| BARRETT THORNHILL | — |
| DERRICK M WHITE | — |
| MICHAEL ALEXANDER WILLIAMS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.